17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Elavl3 is essential for the maintenance of Purkinje neuron axons

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neuronal Elav-like (nElavl or neuronal Hu) proteins are RNA-binding proteins that regulate RNA stability and alternative splicing, which are associated with axonal and synaptic structures. nElavl proteins promote the differentiation and maturation of neurons via their regulation of RNA. The functions of nElavl in mature neurons are not fully understood, although Elavl3 is highly expressed in the adult brain. Furthermore, possible associations between nElavl genes and several neurodegenerative diseases have been reported. We investigated the relationship between nElavl functions and neuronal degeneration using Elavl3 −/− mice. Elavl3 −/− mice exhibited slowly progressive motor deficits leading to severe cerebellar ataxia, and axons of Elavl3 −/− Purkinje cells were swollen (spheroid formation), followed by the disruption of synaptic formation of axonal terminals. Deficit in axonal transport and abnormalities in neuronal polarity was observed in Elavl3 −/− Purkinje cells. These results suggest that nElavl proteins are crucial for the maintenance of axonal homeostasis in mature neurons. Moreover, Elavl3 −/− mice are unique animal models that constantly develop slowly progressive axonal degeneration. Therefore, studies of Elavl3 −/− mice will provide new insight regarding axonal degenerative processes.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          Kinesin superfamily motor proteins and intracellular transport.

          Intracellular transport is fundamental for cellular function, survival and morphogenesis. Kinesin superfamily proteins (also known as KIFs) are important molecular motors that directionally transport various cargos, including membranous organelles, protein complexes and mRNAs. The mechanisms by which different kinesins recognize and bind to specific cargos, as well as how kinesins unload cargo and determine the direction of transport, have now been identified. Furthermore, recent molecular genetic experiments have uncovered important and unexpected roles for kinesins in the regulation of such physiological processes as higher brain function, tumour suppression and developmental patterning. These findings open exciting new areas of kinesin research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.

            We identified axonal defects in mouse models of Alzheimer's disease that preceded known disease-related pathology by more than a year; we observed similar axonal defects in the early stages of Alzheimer's disease in humans. Axonal defects consisted of swellings that accumulated abnormal amounts of microtubule-associated and molecular motor proteins, organelles, and vesicles. Impairing axonal transport by reducing the dosage of a kinesin molecular motor protein enhanced the frequency of axonal defects and increased amyloid-beta peptide levels and amyloid deposition. Reductions in microtubule-dependent transport may stimulate proteolytic processing of beta-amyloid precursor protein, resulting in the development of senile plaques and Alzheimer's disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Axon degeneration mechanisms: commonality amid diversity.

              A wide range of insults can trigger axon degeneration, and axons respond with diverse morphology, topology and speed. However, recent genetic, immunochemical, morphological and pharmacological investigations point to convergent degeneration mechanisms. The principal convergence points - poor axonal transport, mitochondrial dysfunction and an increase in intra-axonal calcium - have been identified by rescuing axons with the slow Wallerian degeneration gene (Wld(S)) and studies with blockers of sodium or calcium influx. By understanding how the pathways fit together, we can combine our knowledge of mechanisms, and potentially also treatment strategies, from different axonal disorders.
                Bookmark

                Author and article information

                Contributors
                hjokano@jikei.ac.jp
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                9 February 2018
                9 February 2018
                2018
                : 8
                : 2722
                Affiliations
                [1 ]ISNI 0000 0001 0661 2073, GRID grid.411898.d, Division of Regenerative Medicine, , The Jikei University School of Medicine, ; 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105–8461 Japan
                [2 ]ISNI 0000 0004 1936 9959, GRID grid.26091.3c, Department of Physiology, , Keio University School of Medicine, ; 35 Shinanomachi, Shinjuku-ku, Tokyo, 160–8582 Japan
                [3 ]GRID grid.474690.8, Laboratory for Marmoset Neural Architecture, , Brain Science Institute RIKEN, ; 2-1 Hirosawa, Wako, Saitama, 351–0198 Japan
                [4 ]ISNI 0000 0001 2173 7691, GRID grid.39158.36, Department of Anatomy, , Hokkaido University Graduate School of Medicine, ; Kita 15, Nishi 7, Kita-ku, Sapporo, 060–8638 Japan
                [5 ]ISNI 0000 0004 1762 2738, GRID grid.258269.2, Department of Cellular and Molecular Neuropathology, , Juntendo University Graduate School of Medicine, ; 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113–8421 Japan
                [6 ]ISNI 0000 0000 9269 4097, GRID grid.256642.1, Department of Neurophysiology & Neural Repair, , Gunma University Graduate School of Medicine, ; 3-39-22 Showa-machi, Maebashi, Gunma, 371–8511 Japan
                [7 ]ISNI 0000 0000 9269 4097, GRID grid.256642.1, Research Program for Neural Signaling, Division of Endocrinology, Metabolism and Signal research, , Gunma University Initiative for Advanced Research, ; 3-39-22 Showa-machi, Maebashi, Gunma, 371–8511 Japan
                [8 ]ISNI 0000 0001 2166 1519, GRID grid.134907.8, Laboratory of Molecular Neuro-Oncology and Howard Hughes Medical Institute, , The Rockefeller University, ; 1230 York Avenue, New York, NY 10065 USA
                [9 ]ISNI 0000 0004 0623 246X, GRID grid.417982.1, Present Address: Immunoregulation for the treatment of inflammation-related disorders, IBRI Laboratory, , Foundation for Biomedical Research and Innovation, ; 2-2 Minatojima-minamimachi Chuo-ku, Kobe, 650-0047 Japan
                Author information
                http://orcid.org/0000-0001-9382-396X
                http://orcid.org/0000-0002-5134-8088
                Article
                21130
                10.1038/s41598-018-21130-5
                5807307
                29426875
                7bfe8f4b-3b46-4404-9c6a-b1ba603f19b4
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 13 October 2017
                : 30 January 2018
                Categories
                Article
                Custom metadata
                © The Author(s) 2018

                Uncategorized
                Uncategorized

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content245

                Cited by23

                Most referenced authors771